Novel |
BAIAP3 |
BAI1 associated protein 3 |
|
|
|
Novel |
CASP4 |
caspase 4 |
- NOD1/2 Signaling Pathway
- Pyroptosis
- CASP4 inflammasome assembly
- Microbial factors inhibit CASP4 activity
- CASP4-mediated substrate cleavage
|
|
|
Novel |
CFB |
complement factor B |
- Alternative complement activation
- Activation of C3 and C5
- Regulation of Complement cascade
|
- Zinc
- 4-guanidinobenzoic acid
- Diisopropylphosphono Group
- MLN2222
- Zinc acetate
|
- Alternative complement pathway component defects, including the following four diseases: Factor B deficiency; Factor D deficiency; Factor H deficiency; Properdin deficiency
|
Novel |
KCNA1 |
potassium voltage-gated channel subfamily A member 1 |
- Voltage gated Potassium channels
|
- Enflurane
- Amitriptyline
- Isoflurane
- Methoxyflurane
- Promethazine
- Miconazole
- Desflurane
- Dalfampridine
- Tetraethylammonium
- Amifampridine
|
|
Novel |
MPV17L |
MPV17 mitochondrial inner membrane protein like |
|
|
|
Novel |
NDE1 |
nudE neurodevelopment protein 1 |
- Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal
- Separation of Sister Chromatids
- Resolution of Sister Chromatid Cohesion
- Regulation of PLK1 Activity at G2/M Transition
- Loss of Nlp from mitotic centrosomes
- Recruitment of mitotic centrosome proteins and complexes
- Loss of proteins required for interphase microtubule organization from the centrosome
- Recruitment of NuMA to mitotic centrosomes
- Anchoring of the basal body to the plasma membrane
- RHO GTPases Activate Formins
- Mitotic Prometaphase
- AURKA Activation by TPX2
- EML4 and NUDC in mitotic spindle formation
|
|
|
Novel |
NHERF4 |
NHERF family PDZ scaffold protein 4 |
- Intestinal infectious diseases
|
|
|
Novel |
NTAN1 |
N-terminal asparagine amidase |
|
|
|
Novel |
PPIE |
peptidylprolyl isomerase E |
- Formation of TC-NER Pre-Incision Complex
- Transcription-Coupled Nucleotide Excision Repair (TC-NER)
- Dual incision in TC-NER
- Gap-filling DNA repair synthesis and ligation in TC-NER
- Neutrophil degranulation
- mRNA Splicing - Major Pathway
|
|
|
Novel |
VWF |
von Willebrand factor |
- Platelet degranulation
- Intrinsic Pathway of Fibrin Clot Formation
- Integrin cell surface interactions
- Integrin signaling
- GRB2:SOS provides linkage to MAPK signaling for Integrins
- p130Cas linkage to MAPK signaling for integrins
- GP1b-IX-V activation signalling
- MAP2K and MAPK activation
- Signaling by moderate kinase activity BRAF mutants
- Signaling by high-kinase activity BRAF mutants
- Signaling by BRAF and RAF1 fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- Platelet Adhesion to exposed collagen
- Platelet Aggregation (Plug Formation)
- Signaling downstream of RAS mutants
- Signaling by RAF1 mutants
- Defective F8 cleavage by thrombin
- Defective F8 binding to von Willebrand factor
- Enhanced cleavage of VWF variant by ADAMTS13
- Enhanced binding of GP1BA variant to VWF multimer:collagen
- Defective VWF cleavage by ADAMTS13 variant
- Defective VWF binding to collagen type I
- Defective binding of VWF variant to GPIb:IX:V
|
- Antihemophilic factor, human recombinant
- Egaptivon pegol
- Caplacizumab
- Simoctocog alfa
- Antihemophilic factor (recombinant), PEGylated
- Susoctocog alfa
- Efmoroctocog alfa
- Lonoctocog alfa
- Moroctocog alfa
- Turoctocog alfa pegol
- Rurioctocog alfa pegol
|
- Hemophilia; Hemophilia A (HEMA); Hemophilia B (HEMB); von Willebrand disease (VWD)
|
Novel |
ZNF75A |
zinc finger protein 75A |
- Generic Transcription Pathway
|
|
|
|
ATF7IP |
activating transcription factor 7 interacting protein |
- PKMTs methylate histone lysines
- Regulation of endogenous retroelements by KRAB-ZFP proteins
- Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex
- Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex
|
|
|
|
BAG6 |
BAG cochaperone 6 |
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
|
|
|
|
DLG4 |
discs large MAGUK scaffold protein 4 |
- Signaling by ERBB4
- Trafficking of AMPA receptors
- Unblocking of NMDA receptors, glutamate binding and activation
- Unblocking of NMDA receptors, glutamate binding and activation
- Ras activation upon Ca2+ influx through NMDA receptor
- NrCAM interactions
- Activation of Ca-permeable Kainate Receptor
- RHO GTPases activate CIT
- RAF/MAP kinase cascade
- LGI-ADAM interactions
- Neurexins and neuroligins
- Neurexins and neuroligins
- Synaptic adhesion-like molecules
- Assembly and cell surface presentation of NMDA receptors
- Negative regulation of NMDA receptor-mediated neuronal transmission
- Long-term potentiation
|
- Guanidine
- Guanosine-5'-Monophosphate
|
|
|
ECT2 |
epithelial cell transforming 2 |
- NRAGE signals death through JNK
- G alpha (12/13) signalling events
- RHOA GTPase cycle
- RHOB GTPase cycle
- CDC42 GTPase cycle
- RAC1 GTPase cycle
|
|
|
|
EXOSC10 |
exosome component 10 |
- Major pathway of rRNA processing in the nucleolus and cytosol
- Nuclear RNA decay
|
|
|
|
NCLN |
nicalin |
|
|
|
|
SHBG |
sex hormone binding globulin |
|
- Masoprocol
- Diethylstilbestrol
- Levonorgestrel
- Progesterone
- Spironolactone
- Toremifene
- Estrone
- Tamoxifen
- Clomifene
- Dienestrol
- Hesperetin
- Zinc
- Genistein
- Naringenin
- Quercetin
- 4'-Hydroxyflavanone
- Afimoxifene
- Estriol
- Phenolphthalein
- Norethynodrel
- Dioxybenzone
- Zeranol
- Gestrinone
- Equol
- Zinc acetate
- Zinc chloride
- Zinc sulfate, unspecified form
- Estriol tripropionate
|
|
|
STAT1 |
signal transducer and activator of transcription 1 |
- Interleukin-6 signaling
- ISG15 antiviral mechanism
- Signaling by SCF-KIT
- Signaling by cytosolic FGFR1 fusion mutants
- Downstream signal transduction
- Interleukin-4 and Interleukin-13 signaling
- Interleukin-20 family signaling
- Regulation of RUNX2 expression and activity
- Interleukin-35 Signalling
- Interleukin-9 signaling
- NOTCH3 Intracellular Domain Regulates Transcription
- NOTCH3 Intracellular Domain Regulates Transcription
- Interleukin-27 signaling
- Interleukin-21 signaling
- Interferon alpha/beta signaling
- Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
- Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
- Signaling by PDGFRA extracellular domain mutants
- Signaling by CSF3 (G-CSF)
- Signaling by CSF1 (M-CSF) in myeloid cells
- Inactivation of CSF3 (G-CSF) signaling
- SARS-CoV-2 activates/modulates innate and adaptive immune responses
- Signaling by ALK fusions and activated point mutants
- Growth hormone receptor signaling
- PKR-mediated signaling
- Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
- Regulation of PD-L1(CD274) transcription
|
|
- Chronic Mucocutaneous Candidiasis (CMC); Familial candidiasis (CANDF)
- IFN-gamma/IL-12 axis, including the following five diseases: IL-12 p40 subunit deficiency; IL-12 receptor (IL-12R) beta1 chain deficiency; IFN-gamma receptor (IFN gamma R) alpha chain deficiency; IFN-gamma receptor (IFN gamma R) beta chain deficiency; STAT-1 deficiency
|
|
TOM1L1 |
target of myb1 like 1 membrane trafficking protein |
|
|
|